Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer
Clinical trial NCT01815242 · COMPLETED
Trial details
- NCT number
- NCT01815242
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-03-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.